Biotech Cos. Settle Trade Secrets Spat

Law360, New York (April 16, 2007, 12:00 AM EDT) -- Two biotechnology companies that specialize in treatments for Vitamin D deficiency have agreed to settle a trade secrets dispute that was initiated after three employees left one firm for the other.

Genzyme Corp. and Cytochroma Inc. on Monday announced they had reached an amicable settlement over the lawsuit brought by Genzyme. The terms of the accord, and many details of the complaint, are under seal.

"Cytochroma has remained on track for meeting its financing and clinical development milestones despite the intercurrent lawsuit," said Alan Lewis, chairman...
To view the full article, register now.